Utility of Plasma Free Metanephrines for Detecting Childhood Pheochromocytoma
Martina Weise,
Deborah P. Merke,
Karel Pacak,
McClellan M. Walther and
Graeme Eisenhofer
Developmental Endocrinology Branch (M.W.), Pediatric and Reproductive Endocrinology Branch (D.P.M., K.P.), National Institute of Child Health and Human Development; Clinical Neurocardiology Section (G.E.), National Institute of Neurological Disorders and Stroke; Urologic Oncology Branch (M.M.W.), National Cancer Institute; and the Warren Grant Magnuson Clinical Center (D.P.M.), National Institutes of Health, Bethesda, Maryland 20892
Address all correspondence and requests for reprints to: Graeme Eisenhofer, Ph.D., Building 10, Room 6N252, National Institutes of Health, 10 Center Drive, MSC 1620, Bethesda, Maryland 20892-1620. E-mail: . ge{at}box-g.nih.gov
Abstract
Measurements of plasma free metanephrines, normetanephrine (NMN)and metanephrine (MN), provide a sensitive test for diagnosisof pheochromocytoma in adults but have not been evaluated inchildren. We therefore established reference ranges for plasmaand urinary metanephrines and the catecholamines, norepinephrine(NE) and epinephrine (E), in 86 healthy children (age 517).A group of 158 healthy adults (age 1872) served as acomparison group. Pediatric reference ranges were applied toexamine the diagnostic utility of the various tests in 45 childrenevaluated for pheochromocytoma (age 817; 38 with vonHippel-Lindau syndrome), with tumors found on 12 occasions.Upper reference limits for E and MN were higher and those forNE and NMN lower in children than in adults. Boys had higherplasma levels of E and MN and higher urinary excretion of allfour amines than girls. Plasma free metanephrines provided adiagnostic test with values for sensitivity (100%) and specificity(94%) that were equal to or higher than those of other tests.In two children screened for pheochromocytoma on multiple occasions,use of pediatric reference ranges for plasma free metanephrinesindicated the tumor a year earlier than indicated using adultreference ranges. The findings indicate that plasma free metanephrinesprovide a sensitive tool for detection of pheochromocytoma inchildren. Age appropriate reference ranges should be used andgender differences should be considered.
This article has been cited by other articles:
W. Yuan, W. Wang, B. Cui, T. Su, Y. Ge, L. Jiang, W. Zhou, and G. Ning Overexpression of ERBB-2 was more frequently detected in malignant than benign pheochromocytomas by multiplex ligation-dependent probe amplification and immunohistochemistry
Endocr. Relat. Cancer,
March 1, 2008;
15(1):
343 - 350.
[Abstract][Full Text][PDF]
Y. B. Sverrisdottir, T. Mogren, J. Kataoka, P. O. Janson, and E. Stener-Victorin Is polycystic ovary syndrome associated with high sympathetic nerve activity and size at birth?
Am J Physiol Endocrinol Metab,
March 1, 2008;
294(3):
E576 - E581.
[Abstract][Full Text][PDF]
M. d'Herbomez, G. Forzy, C. Bauters, C. Tierny, P. Pigny, B. Carnaille, F. Pattou, J.-L. Wemeau, and N. Rouaix An analysis of the biochemical diagnosis of 66 pheochromocytomas
Eur. J. Endocrinol.,
May 1, 2007;
156(5):
569 - 575.
[Abstract][Full Text][PDF]
J. Sullivan, T. Groshong, and J. D. Tobias Presenting Signs and Symptoms of Pheochromocytoma in Pediatric-aged Patients
Clinical Pediatrics,
October 1, 2005;
44(8):
715 - 719.
[Abstract][PDF]
M. S. Lora, S. G. Waguespack, J. F. Moley, and E. C. Walvoord Adrenal Ganglioneuromas in Children with Multiple Endocrine Neoplasia Type 2: A Report of Two Cases
J. Clin. Endocrinol. Metab.,
July 1, 2005;
90(7):
4383 - 4387.
[Abstract][Full Text][PDF]
L. Jackson, F. L. R. Williams, A. Burchell, M. W. H. Coughtrie, and R. Hume Plasma Catecholamines and the Counterregulatory Responses to Hypoglycemia in Infants: A Critical Role for Epinephrine and Cortisol
J. Clin. Endocrinol. Metab.,
December 1, 2004;
89(12):
6251 - 6256.
[Abstract][Full Text][PDF]
S. A. Lagerstedt, D. J. O'Kane, and R. J. Singh Measurement of Plasma Free Metanephrine and Normetanephrine by Liquid Chromatography-Tandem Mass Spectrometry for Diagnosis of Pheochromocytoma
Clin. Chem.,
March 1, 2004;
50(3):
603 - 611.
[Abstract][Full Text][PDF]
Y. C. Kudva, A. M. Sawka, and W. F. Young Jr. The Laboratory Diagnosis of Adrenal Pheochromocytoma: The Mayo Clinic Experience
J. Clin. Endocrinol. Metab.,
October 1, 2003;
88(10):
4533 - 4539.
[Full Text][PDF]